Get the Stockscreener App
0.40
8.74%
-0.035
Optinose Inc stock is traded at $0.40, with a volume of 1.53M.
It is down -8.74% in the last 24 hours and down -50.38% over the past month.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
See More
Previous Close:
$0.435
Open:
$0.45
24h Volume:
1.53M
Relative Volume:
3.22
Market Cap:
$59.57M
Revenue:
$70.99M
Net Income/Loss:
$-35.48M
P/E Ratio:
-0.80
EPS:
-0.5
Net Cash Flow:
$-20.86M
1W Performance:
-48.32%
1M Performance:
-50.38%
6M Performance:
-68.49%
1Y Performance:
-68.24%
1-Day Range:
$0.3807
$0.45
1-Week Range:
$0.3807
$0.69
52-Week Range:
$0.3807
$2.10
Optinose Inc Stock (OPTN) Company Profile
Name
Optinose Inc
Sector
Phone
267-364-3500
Address
777 TOWNSHIP LINE ROAD, YARDLEY, PA
Compare OPTN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| OPTN | 0.3971 | 59.57M | 70.99M | -35.48M | -20.86M | -0.50 |
| ZTS | 176.31 | 79.52B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.58 | 43.13B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.425 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.41 | 18.56B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 12.99 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-22 | Resumed | Jefferies | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-19 | Initiated | Cowen | Outperform |
| Aug-08-18 | Initiated | Cantor Fitzgerald | Overweight |
Optinose Inc Stock (OPTN) Latest News
FY2024 EPS Estimates for OptiNose Increased by HC Wainwright - Defense World
Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50 - Simply Wall St
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
FY2024 EPS Estimates for OptiNose Raised by HC Wainwright - MarketBeat
Great Point Partners LLC Bolsters Position in OptiNose Inc - GuruFocus.com
HC Wainwright Reaffirms Buy Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Given Buy Rating at HC Wainwright - MarketBeat
OptiNose, Inc. (NASDAQ:OPTN) Q3 2024 Earnings Call Transcript - Insider Monkey
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Gr - GuruFocus.com
OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance - Yahoo Finance
FMR LLC's Strategic Acquisition of OptiNose Inc Shares - GuruFocus.com
OptiNose stock hits 52-week low at $0.63 amid market challenges - Investing.com
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - Yahoo Finance
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
Optinose Slashes 2024 Revenue Guidance Despite Q3 Growth; XHANCE Sales Up 3% | OPTN Stock News - StockTitan
OptiNose Inc (OPTN) Quarterly 10-Q Report - Quartzy
OptiNose Inc (OPTN) Q3 2024 Earnings Report Preview: What To Exp - GuruFocus.com
OptiNose (OPTN) Scheduled to Post Earnings on Tuesday - MarketBeat
Optinose (OPTN) Sets Q3 2024 Earnings Call for November 12What to Expect | OPTN Stock News - StockTitan
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results - GlobeNewswire
Head to Head Review: OPKO Health (NASDAQ:OPK) vs. OptiNose (NASDAQ:OPTN) - Defense World
Insiders In OptiNose Left Out From 19% Price Rise After Disposing Stock - Simply Wall St
Positive week for OptiNose, Inc. (NASDAQ:OPTN) institutional investors who lost 24% over the past year - Yahoo Finance
Rosalind Advisors, Inc. Expands Stake in OptiNose Inc - GuruFocus.com
Optinose Grants Stock Options to Attract New Talent - MSN
OptiNose faces potential Nasdaq delisting over share price - Investing.com India
OptiNose faces potential Nasdaq delisting over share price By Investing.com - Investing.com Australia
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Squarepoint Ops LLC Has $178,000 Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
OptiNose Inc (OPTN) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - Yahoo Finance
Optinose Appoints Terry Kohler as Chief Financial Officer - MyChesCo
OptiNose Names Terry Kohler New CFO with Incentive Grant - TipRanks
Optinose names Terry Kohler as new CFO - Investing.com
Optinose Names Terry Kohler as CFO - MarketWatch
Optinose names Terry Kohler as new CFO By Investing.com - Investing.com UK
Keeping an Eye on OptiNose Inc (OPTN) After Insider Trading Activity - Knox Daily
XTX Topco Ltd Purchases New Position in OptiNose, Inc. (NASDAQ:OPTN) - Defense World
2,350,010 Shares in OptiNose, Inc. (NASDAQ:OPTN) Purchased by Stonepine Capital Management LLC - Defense World
OptiNose, Inc. (NASDAQ:OPTN) Shares Acquired by Nantahala Capital Management LLC - Defense World
Understanding OPTN’s financial ratios: A beginner’s guide - US Post News
Stonepine Capital Management LLC Invests $2.44 Million in OptiNose, Inc. (NASDAQ:OPTN) - MarketBeat
OptiNose stock hits 52-week low at $0.68 amid market challenges By Investing.com - Investing.com South Africa
OptiNose stock hits 52-week low at $0.68 amid market challenges - Investing.com Canada
Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch - Simply Wall St
OptiNose announces board member resignation By Investing.com - Investing.com Canada
OptiNose announces board member resignation - Investing.com India
Optinose Inc Stock (OPTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optinose Inc Stock (OPTN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mahmoud Ramy A | Chief Executive Officer |
Sep 17 '24 |
Sale |
0.87 |
4,881 |
4,246 |
1,202,097 |
0.72%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):